Clinical trial
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic…
NCT03233126 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT03233126 |
|---|---|
| Title | A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia |
| Official title | A Phase 3 Open-Label Trial to Assess the Efficacy and Safety of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia and a Postmarketing Study of KRN23 Switched From the Phase 3 Trial |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | X-linked Hypophosphatemic Rickets/Osteomalacia |
| Intervention type | Drug |
| Interventions | KRN23 |
| Enrollment | 16 |
| Start date | Jul 6, 2017 |
| Primary completion | Feb 17, 2020 |
| Completion | Feb 17, 2020 |
| First posted | Jul 28, 2017 |
| Last update posted | Sep 6, 2022 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: